We use cookies to provide you with a better experience. By continuing to browse the site you are agreeing to our use of cookies in accordance with our Cookie Policy.
Accept
Home » FDA Extends Electronic Submission Deadline for Type III Drug Master Files
The item has been added to your shopping cart.
FDA Extends Electronic Submission Deadline for Type III Drug Master Files
The FDA issued final guidance on electronic submissions of drug master files, giving sponsors of Type III DMFs for packaging materials an extra year before submission requirements kick in.
To View This Article:
Login
Subscribe To International Pharmaceutical Regulatory Monitor